Cargando…

Designer antiandrogens join the race against drug resistance

By using in silico models of the complexes formed by analogues of a cancer drug and its receptor, it may be possible to strategically redesign existing drugs and win the race against mutations that lead to drug resistance in prostate cancer.

Detalles Bibliográficos
Autores principales: Josan, Jatinder S, Katzenellenbogen, John A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622176/
https://www.ncbi.nlm.nih.gov/pubmed/23580166
http://dx.doi.org/10.7554/eLife.00692